Business Context and Reporting Period
This Form 8-K filing by Calyxt, Inc. (not Cibus, Inc.) covers events occurring on June 15, 2018, and June 21, 2018. The report addresses significant changes in executive leadership, specifically within the finance function.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes rather than financial performance data.
Material Changes
- Resignation: Bryan Corkal resigned as Chief Financial Officer (CFO) effective June 15, 2018. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment: Eric Dutang was appointed as interim Chief Financial Officer effective June 21, 2018. He succeeds Mr. Corkal as the principal financial and accounting officer.
- Shareholder Context: Mr. Dutang currently serves as CFO of Cellectis S.A., which owns 70.4% of Calyxt, Inc.'s common stock. Mr. Dutang beneficially owns 60,455 shares of the Company.
Outlook, Risks, and Management Commentary
Management intends to conduct a search for a permanent Chief Financial Officer to replace the interim appointee. The filing explicitly states there are no arrangements or understandings between Mr. Dutang and other persons regarding his appointment, nor does he have family relationships with directors or officers. No material risks or contingencies related to financial performance were disclosed in this specific filing.
Investor Verification Checklist
- Verify the timeline for the search and appointment of a permanent CFO.
- Confirm the extent of Cellectis S.A.'s influence on Calyxt's financial strategy given their 70.4% ownership and the appointment of their CFO as interim leadership.
- Review subsequent filings for any financial disclosures that may have been delayed or impacted by the leadership transition.